Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of a single dose of amisulpride on functional brain changes during reward- and motivation-related processing using task-based fMRI in healthy subjects and patients with major depressive disorder - study protocol for a randomized clinical trial.
Carstens L, Popp M, Keicher C, Hertrampf R, Weigner D, Meiering MS, Luippold G, Süssmuth SD, Beckmann CF, Wunder A, Grimm S. Carstens L, et al. Among authors: wunder a. Trials. 2023 Nov 27;24(1):761. doi: 10.1186/s13063-023-07788-x. Trials. 2023. PMID: 38012795 Free PMC article.
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder.
Grimm S, Keicher C, Paret C, Niedtfeld I, Beckmann C, Mennes M, Just S, Sharma V, Fuertig R, Herich L, Mack S, Thamer C, Schultheis C, Weigand A, Schmahl C, Wunder A. Grimm S, et al. Among authors: wunder a. Eur Neuropsychopharmacol. 2022 Dec;65:44-51. doi: 10.1016/j.euroneuro.2022.10.009. Epub 2022 Nov 4. Eur Neuropsychopharmacol. 2022. PMID: 36343427 Free article. Clinical Trial.
TRPC4/5 inhibitors: Phase I results and proof of concept studies.
Grimm S, Just S, Fuertig R, Dwyer JB, Sharma VM, Wunder A. Grimm S, et al. Among authors: wunder a. Eur Arch Psychiatry Clin Neurosci. 2024 Sep 29. doi: 10.1007/s00406-024-01890-0. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39343822 Review.
Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.
Meiering MS, Weigner D, Gärtner M, Carstens L, Keicher C, Hertrampf R, Beckmann CF, Mennes M, Wunder A, Weigand A, Grimm S. Meiering MS, et al. Among authors: wunder a. Transl Psychiatry. 2024 Oct 14;14(1):436. doi: 10.1038/s41398-024-03120-6. Transl Psychiatry. 2024. PMID: 39402015 Free PMC article. Clinical Trial.
Correction: Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.
Meiering MS, Weigner D, Gärtner M, Carstens L, Keicher C, Hertrampf R, Beckmann CF, Mennes M, Wunder A, Weigand A, Grimm S. Meiering MS, et al. Among authors: wunder a. Transl Psychiatry. 2024 Dec 4;14(1):483. doi: 10.1038/s41398-024-03191-5. Transl Psychiatry. 2024. PMID: 39632823 Free PMC article. No abstract available.
94 results